Dr. David Kerr discusses time to tumor growth, a metric that outscored all other means of characterizing tumor response rate and correlated with overall survival in patients with colorectal cancer.

Many doctors consider mandatory drug testing for health professionals an insult, but if we're going to improve quality of patient care, it makes sense, says bioethicist Art Caplan.

New developments have prompted a revision of CDC guidance for HCV antibody testing.

A Skype conversation between Drs. Tony Mok and Giorgio Scagliotti details the efficacy and potential toxicities of afatinib, which is newly approved by the FDA for EGFR-positive lung cancer patients.

The vast majority of monogenic diabetes is misdiagnosed as either type 1 or type 2 diabetes, leading to poor disease management.

It has been suggested that using organs voluntarily donated by prisoners could help ease the shortage. Bioethicist Art Caplan says it's wrong on many levels.

Drs. David Kerr and John Marshall discuss colorectal cancer highlights from ASCO, including findings on follow-up scans, chemo holidays, and drug combos.